Efficacy and safety of irbesartan/hydrochlorothiazide as initial therapy in subgroups of patients with moderate to severe hypertension at high cardiovascular risk

被引：0
|
作者：
Neutel, J.
Bhaumik, A.
Ptaszynska, A.
Franklin, S.
LaPuerta, P.
机构：
[1] Orange Cty Res Ctr, Tustin, CA USA
[2] Bristol Meyers Squibb, Princeton, NJ USA
[3] Univ Calif Irvine, Irvine, CA USA
来源：
JOURNAL OF HYPERTENSION | 2007年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S112 / S113
页数：2
相关论文
共 50 条
  • [41] Tolerability and Efficacy of Fosinopril and Hydrochlorothiazide Compared with Amiloride and Hydrochlorothiazide in Patients with Mild to Moderate Hypertension
    Ravi Saini
    M. Romanini
    L. Mos
    Clinical Drug Investigation, 1998, 15 : 91 - 99
  • [42] Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension
    Fogari, Roberto
    Taddei, Stefano
    Holm-Bentzen, Merete
    Baszak, Jacek
    Melani, Lorenzo
    Schumacher, Kai
    CLINICAL DRUG INVESTIGATION, 2010, 30 (09) : 581 - 597
  • [43] CONCOMITANT THERAPY WITH LABETALOL AND HYDROCHLOROTHIAZIDE IN MODERATE TO MODERATELY SEVERE ESSENTIAL-HYPERTENSION
    KOCHAR, MS
    TYSON, J
    KALBFLEISCH, JH
    JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (06): : 433 - 436
  • [44] Antihypertensive efficacy of hydrochlorothiazide 12.5 mg in patients with mild to moderate hypertension
    Roque, F
    Mon, G
    Cravero, C
    Courreges, J
    Deschle, H
    Scandone, M
    Palumbo, JL
    Ballester, AE
    Murua, J
    ADVANCES IN THERAPY, 1996, 13 (05) : 284 - 291
  • [45] Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54-Week, Open-Label Study
    Murray, Alexander V.
    Koenig, Wolfgang
    Garcia-Puig, Juan
    Patel, Samir
    Uddin, Alkaz
    Zhang, Jack
    JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (12): : 821 - 827
  • [46] Irbesartan and low-dose hydrochlorothiazide combination as long-term therapy for mild-to-moderate hypertension
    Raskin, P
    Saini, R
    Kassler-Taub, K
    Mulhall, L
    Freitag, S
    JOURNAL OF HYPERTENSION, 1998, 16 : S239 - S239
  • [47] Efficacy of candesartan cilexetil alone or in combination with amlodipine and hydrochlorothiazide in moderate-to-severe hypertension
    MacGregor, GA
    Viskoper, JR
    Antonios, TFT
    He, FJ
    HYPERTENSION, 2000, 36 (03) : 454 - 460
  • [48] Comparison of the Efficacy and Safety of Irbesartan and Olmesartan in Patients With Hypertension (EARTH Study)
    Morii, Joji
    Miura, Shin-ichiro
    Shiga, Yuhei
    Sugihara, Makoto
    Arimura, Tadaaki
    Sako, Hideto
    Zhang, Bo
    Uehara, Yoshinari
    Saku, Keijiro
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2012, 34 (05) : 342 - 349
  • [49] Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndrome
    W Krone
    M Hanefeld
    H-F Meyer
    T Jung
    M Bartlett
    C-M Yeh
    I Rajman
    M F Prescott
    W P Dole
    Journal of Human Hypertension, 2011, 25 : 186 - 195
  • [50] SAFETY AND EFFICACY OF AMLODIPINE ADDED TO HYDROCHLOROTHIAZIDE THERAPY IN ESSENTIAL-HYPERTENSION
    GLASSER, SP
    CHRYSANT, SG
    GRAVES, J
    ROFMAN, B
    KOEHN, DK
    AMERICAN JOURNAL OF HYPERTENSION, 1989, 2 (03) : 154 - 157
12345